BFS
FOLD

Bare Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Bare Financial Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.12K Hold
216
– – ﹤0.01% 835
2025
Q4 		$3.08K Buy
216
+81
+60% +$796 ﹤0.01% 716
2025
Q3 		$1.06K Buy
+135
New +$961 ﹤0.01% 1002

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bare Financial Services's FOLD Position: Q1 2026 in Review

Bare Financial Services held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 216 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Bare Financial Services first reported a position in FOLD in Q3 2025 and has held it in 3 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Bare Financial Services held 216 shares of Amicus Therapeutics worth $3.12K as of Q1 2026.
  • Bare Financial Services left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #835 holding.
  • Bare Financial Services first reported a position in Amicus Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.